AKBA R&D Expenses
Akebia Therapeutics Inc · R&D Expenses
AKBA R&D Expenses
Latest reported$70.14Mperiod ending
AKBA TTM R&D Expenses ($10.78M → $70.14M)
TTM R&D Expenses
High-resolution chart · PNG
AKBA r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 70,140,000 | |
| 67,094,000 | |
| 62,041,000 | |
| 47,179,000 | |
| 41,040,000 | |
| 37,674,000 | |
| 37,651,000 | |
| 35,730,000 | |
| 40,573,000 | |
| 53,123,000 | |
| 63,078,000 | |
| 85,117,000 | |
| 99,815,000 | |
| 105,645,000 | |
| 129,792,000 | |
| 127,444,000 | |
| 139,887,000 | |
| 151,074,000 | |
| 147,852,000 | |
| 155,874,000 | |
| 162,260,000 | |
| 177,865,000 | |
| 218,485,000 | |
| 261,319,000 | |
| 288,974,000 | |
| 321,849,000 | |
| 322,969,000 | |
| 329,670,000 | |
| 325,792,000 | |
| 312,015,000 | |
| 291,068,000 | |
| 272,337,000 | |
| 260,414,000 | |
| 232,248,000 | |
| 230,893,000 | |
| 195,946,000 | |
| 168,473,000 | |
| 155,599,000 | |
| 115,785,000 | |
| 94,889,000 | |
| 79,441,000 | |
| 55,746,000 | |
| 43,016,000 | |
| 37,545,000 | |
| 28,403,000 | |
| 26,745,895 | |
| 25,398,823 | |
| 21,521,423 | |
| 18,113,423 | |
| 15,041,528 | |
| 10,781,395 | |
| 8,157,266 |